Business · 11/05/2026Updated: 10/16/2026 · 1 min read
Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
Summary
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is actively seeking licensees to develop inhibitory transmembrane adapter proteins for T-cell immunotherapy in treating cancer, infectious diseases, and autoimmune diseases.